Extendicare (TSE:EXE – Free Report) had its target price upped by TD Securities from C$8.00 to C$9.00 in a report released on Wednesday, BayStreet.CA reports. The firm currently has a hold rating on the stock.
Separately, Royal Bank of Canada raised their price objective on shares of Extendicare from C$8.00 to C$8.50 and gave the company a sector perform rating in a research report on Tuesday, May 21st.
Get Our Latest Analysis on Extendicare
Extendicare Price Performance
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. The firm had revenue of C$348.48 million for the quarter, compared to analysts’ expectations of C$360.20 million. Extendicare had a return on equity of 37.03% and a net margin of 2.63%. Sell-side analysts predict that Extendicare will post 0.4699088 earnings per share for the current year.
Extendicare Dividend Announcement
The firm also recently declared a monthly dividend, which will be paid on Monday, September 16th. Shareholders of record on Friday, August 30th will be paid a $0.04 dividend. The ex-dividend date is Friday, August 30th. This represents a $0.48 annualized dividend and a yield of 5.86%. Extendicare’s payout ratio is 117.07%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Further Reading
- Five stocks we like better than Extendicare
- What is the NASDAQ Stock Exchange?
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 8/12 – 8/16
- How to Find Undervalued Stocks
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.